Open AccessDiabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan
Author(s) -
Onishi Yukiko,
Yoshida Yoko,
Takao Toshiko,
Tahara Tazu,
Kikuchi Takako,
Kobori Toshiko,
Kubota Tetsuya,
Shimmei Asuka,
Iwamoto Masahiko,
Kasuga Masato
Publication year - 2022
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13546
Subject(s) - medicine , telemedicine , glycated hemoglobin , emergency department , emergency medicine , body mass index , retrospective cohort study , glycemic , pandemic , diabetes mellitus , medical emergency , logistic regression , disease , diabetes management , type 2 diabetes , covid-19 , health care , infectious disease (medical specialty) , nursing , endocrinology , economics , economic growth
The purpose of this retrospective cohort study at a Tokyo diabetes clinic was to evaluate the effect of telemedicine and clinic visit on glycated hemoglobin (HbA1c) during the coronavirus disease 2019 state of emergency. The effect of telemedicine and clinic visit during the emergency period on the post‐emergency measured HbA1c was evaluated by multiple regression models and logistic regression models adjusted for age, sex, type of diabetes, pre‐emergency HbA1c and body mass index, and body mass index change during the emergency period. Among 2,727 patients who visited the clinic before and after the emergency period, the interval between clinic visits during the emergency period was significantly associated with HbA1c improvement. Telemedicine and clinic visit were independently associated with HbA1c improvement when pre‐emergency HbA1c was ≥7%. In conclusion, clinic visit and telemedicine during the coronavirus disease 2019 emergency period were both independently effective in HbA1c improvement in Japanese diabetes patients who had insufficient HbA1c control.